SHARPIN restrains IL-33 release by stromal cells to control ILC2 inflammation
Science Advances · 2026
DOI: 10.1126/sciadv.aea2388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Peng Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunology, Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Interleukin-33, Stromal Cells, Lymphocytes, Immunity, Innate. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of China, Tsinghua-Peking Center for Life Sciences.
Abstract (Originalsprache)
Loss of SHARPIN, a component of the linear ubiquitin chain assembly complex (LUBAC), causes systemic inflammation including the accumulation of eosinophils across multiple tissues in mice. However, the mechanisms by which SHARPIN regulates type 2 inflammation remain unclear. Here, we found that SHARPIN deficiency resulted in increased numbers of type 2 innate lymphoid cells (ILC2s) in the lung and other tissues via a cell-extrinsic mechanism. SHARPIN loss enhanced interleukin-33 (IL-33) production by lung stromal cells in vivo and in vitro, thereby promoting ILC2 proliferation. Mechanistically, SHARPIN directly bound IL-33 through its Pleckstrin homology-linker region and restrained IL-33 release independently of its ubiquitination. Combined deficiency of SHARPIN and IL-33 completely reversed ILC2 increase and lung inflammation, but not stromal cell death. Our study reveals a non-canonical, ubiquitin-independent function of SHARPIN as a gatekeeper of IL-33-driven type 2 inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Immunology, Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing 100084, China.
- State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua University, 100084, Beijing, China.
ORCID-Profile: Peng Zeng, Xin Mao, Wen Zhang, Zhiqing Wang, Qian Li, Yun-Cai Liu
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology of China
- Tsinghua-Peking Center for Life Sciences
- Tsinghua University-Xiamen Chang Gung Hospital Joint Research Center for Anaphylactic Diseases
Zitieren
APA
Zeng, P., Mao, X., Zhang, W., Li, J., Wang, Z., Zhang, C., Li, Q., & Liu, Y. C. (2026). SHARPIN restrains IL-33 release by stromal cells to control ILC2 inflammation. Science Advances. https://doi.org/10.1126/sciadv.aea2388
Vancouver
Zeng P, Mao X, Zhang W, Li J, Wang Z, Zhang C, et al. SHARPIN restrains IL-33 release by stromal cells to control ILC2 inflammation. Science Advances. 2026. doi:10.1126/sciadv.aea2388
BibTeX
@article{Zeng2026,
author = {Zeng, Peng and Mao, Xin and Zhang, Wen and Li, Jia and Wang, Zhiqing and Zhang, Chao and Li, Qian and Liu, Yun-Cai},
title = {SHARPIN restrains IL-33 release by stromal cells to control ILC2 inflammation},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aea2388}
}
EUVIMED